Research facility · founded 1898
Roswell Park Comprehensive Cancer Center
Buffalo, United States · roswellpark.org
- Citations, last 5 years
- 77.5k
- Works, last 5 years
- 6 260
- h-index
- 729
- Scientists listed
- 671
- Grants since 2016
- 750
Grants received
2023–2027 · research · R37
Novel synthetic lethality strategy for TP53 mutant colorectal cancer
Christos Fountzilas · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · fellowship · F30
Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression
Jee Eun Choi · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
Craig M. Brackett · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
Theresa E Hahn · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R35
The Genetic Basis of Human DNA Replication Timing
Amnon Koren · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
Boyko S Atanassov · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2025 · fellowship · F31
Examining the impact of laboratory housing temperature on murine CD28 and the response to anti-PD-1
Caitlin M James · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
Brian C Betts · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2027 · research · R37
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
Ethan Vincent Abel · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2023–2028 · research · R50
Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
Aimee B Stablewski · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Assessing pharmacokinetic and pharmacodynamic variability of Δ9-tetrahydrocannabinol delivered from vaping products with and without concurrent use of nicotine
Maciej Lukasz Goniewicz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · research · R21
Tumor and immune cell co-evolutionary dynamics as a source of racial disparities in breast cancer
Angela Omilian · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication
Marilyn L Kwan · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2024 · research · R21
Tumor and immune cell co-evolutionary dynamics as a source of racial disparities in breast cancer
Angela Omilian · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2024 · research · R56
Radiation-induced Salivary Gland Vascular Injury: Mechanisms and Interventions
Mukund Seshadri · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2024 · fellowship · F31
Impact of benzodiazepines on the pancreatic tumor microenvironment
Abigail Carissa Cornwell · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · research · R00
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GVT) Responses
Hemn Mohammadpour · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2025 · research · R01
Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings
Elisa Marie Rodriguez · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
Jia Fang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
Jia Fang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Delineating the dystopian nature of the cell cycle in cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2024 · fellowship · F99
Impact of Numeracy on Risk Perceptions of Tobacco-Related Diseases
Destiny Diaz · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
Brahm H. Segal · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Dissecting the Mechanism of SETDB1 and its K867 Monoubiquitination in Lung Cancer Progression
Jia Fang · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
Brahm H. Segal · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022 · research · R03
Leveraging tissue-specific regulatory maps and network-assisted analysis to identify novel genetic risk loci for esophageal adenocarcinoma
Matthew Frank Buas · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
YAP1 and RB1 cooperate to regulate lung cancer lineage plasticity and therapeutic resistance
David W. Goodrich · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficits
Eugene Yu · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Investigating how stress induced changes in maternal serotonin affect offspring development and stress resilience
Veena Prahlad · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Delineating the dystopian nature of the cell cycle in cancer
Erik Knudsen · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2023 · fellowship · F31
Impact of benzodiazepines on the pancreatic tumor microenvironment
Abigail Carissa Cornwell · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
2022–2027 · research · R01
Implementation of evidence-based strategies to optimize HPV vaccination in rural primary care settings
Elisa Marie Rodriguez · Roswell Park Comprehensive Cancer Center · funded by National Institutes of Health
